ABCDEFGHIJKLMNOPQRSTUVWXYZ
1
DocumentTypeTitledepartmentCollabPartysponsor
Initial Submission
ExpirationDate
fyfundSrcbranch
2
CRADA-Cooperative Research & Development Agreement
COMBINED PHASE 3, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDIES EVALUATING THE EFFICACY AND SAFETY OF FILGOTINIB IN THE INDUCTION AND MAINTENANCE OF REMISSION IN SUBJECTS WITH MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE (895)
DOM - GASTERENTOLOGY SERVICEGENEVAGILEAD SCIENCES, INC.1/13/20206/6/20222020Air Force
3
COOP-Cooperative Agreement Letter
MAJOR EXTREMITY TRAUMA RESEARCH CONSORTIUM (METRC) – EARLY ADVANCED WEIGHT BEARING FOR PERI-ARTICULAR KNEE AND PILON INJURIES: AN RTC USING THE ANTI-GRAVITY TREADMILL (ALTERG)
DOO - ORTHOPAEDIC SERVICEGENEVAWRNMMC12/31/20192020USAMRAAAir Force
4
COOP-Cooperative Agreement Letter
MAJOR EXTREMITY TRAUMA RESEARCH CONSORTIUM (METRC) IMPROVING RECOVERY AFTER ORTHOPAEDIC TRAUMA: COGNITIVE-BEHAVIORAL BASED PHYSICAL THERAPY (CBPT)
DOO - ORTHOPAEDIC SERVICEGENEVAWRNMMC12/18/20192020USAMRAAAir Force
5
COOP-Cooperative Agreement Letter
A PROSPECTIVE STUDY OF EARLY MECHANICAL STABILIZATION AND BLEEDING IN DISRUPTION OF THE PELVIC RING
DOO - ORTHOPAEDIC SERVICEGENEVA12/13/20192020USAMRAA
6
COOP-Cooperative Agreement Letter
DEVELOPMENT OF A SELF-REPORT INSTRUMENT FOR HIGH MOBILITY PROSTHESIS USERS: VALIDATION STUDY
DRM - CENTER FOR THE INTREPIDHJF
UNIVERSITY OF WASHINGTON
12/13/20192020USAMRAACivilian
7
CRADA-Cooperative Research & Development Agreement
STELLARIS: A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF CENICRIVIROC FOR THE TREATMENT OF LIVER FIBROSIS IN ADULT SUBJECTS WITH NONALCOHOLIC STEATOHEPATITIS
DOM - GASTERENTOLOGY SERVICEGENEVAALLERGAN PLC12/11/20194/8/20232020Army
8
COOP-Cooperative Agreement Letter
NEEDS, PREFERENCES AND FUNCTIONAL ABILITIES OF VETERANS AND SERVICE MEMBERS WITH UPPER LIMB AMPUTATION
DRM - CENTER FOR THE INTREPIDHJF12/6/20192020USAMRAACivilian
9
CRADA-Cooperative Research & Development Agreement
A PHASE 3, MULTICENTER, OPEN-LABEL EXTENSION STUDY OF ORAL OZANIMOD FOR MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE
DOM - GASTROENTEROLOGY SERVICEGENEVACELGENE CORP11/27/20192020Army
10
CRADA-Cooperative Research & Development Agreement
A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF ORAL OZANIMOD AS MAINTENANCE THERAPY FOR MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE
DOM - GASTERENTOLOGY SERVICEGENEVACELGENE CORP11/27/20192020Army
11
CRADA-Cooperative Research & Development Agreement
ROMAN: REDUCTION IN ORAL MUCOSITIS WITH AVASOPASEM MANGANESE (GC4419) – PHASE 3 TRIAL IN PATIENTS RECEIVING CHEMORADIOTHERAPY FOR LOCALLY-ADVANCED, NON-METASTATIC HEAD AND NECK CANCER
DOM - HEMOTOLOGY ONCOLOGY SERVICE
GENEVA
GALERA THERAPEUTICS, INC.
11/18/20192020Air Force
12
CRADA-Cooperative Research & Development Agreement
A PHASE 3, MULTICENTER, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF CSL112 IN SUBJECTS WITH ACUTE CORONARY SYNDROME
DOM - CARDIOLOGY SERVICEGENEVACSL BEHRING LLC11/4/20192020Army
13
CRADA-Cooperative Research & Development Agreement
A PHASE 3, MULTINATIONAL, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY OF MGL-3196 (RESMETIROM) IN PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS (NASH) TO RESOLVE NASH AND REDUCE PROGRESSION TO CIRRHOSIS AND/OR HEPATIC DECOMPENSATION
DOM - HEMOTOLOGY ONCOLOGY SERVICE
GENEVA
MADRIGAL PHARMACEUTICALS, INC
10/31/20192020Army
14
COOP-Cooperative Agreement Letter
ULTRASOUND-GUIDED PERCUTANEOUS PERIPHERAL NERVE STIMULATION: A NON-PHARMACOLOGIC ALTERNATIVE FOR THE TREATMENT OF POSTOPERATIVE PAIN.
DOA - ANESTHESIAHJF
UNIVERISTY OF CALIFORNIA
10/4/20192020USAMRAAArmy
15
CRADA-Cooperative Research & Development Agreement
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE III STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ELAFIBRANOR IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS (NASH) AND FIBROSIS
DOM - GASTROENTEROLOGY SERVICEGENEVAGENFIT10/4/201912/14/20212020Army
16
CRADA-Cooperative Research & Development Agreement
ECO-RESET: A PHASE 2B, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE DOSE, MULTICENTER STUDY TO ASSESS EFFICACY AND SAFETY OF SER‑287 IN ADULTS WITH ACTIVE MILD-TO-MODERATE ULCERATIVE COLITIS
DOM - GASTROENTEROLOGY SERVICEGENEVA
SERES THERAPEUTICS, INC.
9/27/20192020Air Force
17
CRADA-Cooperative Research & Development Agreement
THE AIM-HN AND SEQ-HN STUDY: A 2 COHORT, NON-COMPARATIVE, PIVOTAL STUDY EVALUATING THE EFFICACY OF TIPIFARNIB IN PATIENTS WITH HEAD AND NECK SQUAMOUS CELL CARCINOMA (HNSCC) WITH HRAS MUTATIONS (AIM-HN) AND THE IMPACT OF HRAS MUTATIONS ON RESPONSE TO FIRST LINE SYSTEMIC THERAPIES FOR HNSCC (SEQ-HN)
DOM - HEMOTOLOGY ONCOLOGY SERVICE
GENEVAKURA ONCOLOGY, INC.9/26/20192020Air Force
18
CRADA-Cooperative Research & Development Agreement
INDUCTION STUDY #2 - A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF ORAL OZANIMOD AS INDUCTION THERAPY FOR MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE
DOM - GASTROENTEROLOGY SERVICEGENEVACELGENE CORP9/26/20191/24/20242020Air Force
19
CRADA-Cooperative Research & Development Agreement
SMART STEPPED CARE MANAGEMENT FOR LOW BACK PAIN IN MILITARY HEALTH SYSTEM
DRM - PHYSICAL THERAPY SERVICEGENEVAUNIVERSITY OF UTAH9/24/20192020Army
20
CRADA-Cooperative Research & Development Agreement
RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO ASSESS CARDIOVASCULAR OUTCOMES FOLLOWING TREATMENT WITH ERTUGLIFLOZIN (MK-8835/PF-04971729) IN SUBJECTS WITH TYPE 2 DIABETES MELLITUS AND ESTABLISHED VASCULAR DISEASE
DOM - CARDIOLOGY SERVICEGENEVAPFIZER9/18/201910/30/20192019Air Force
21
COOP-Cooperative Agreement Letter
AUTOMATED CONTROL OF VOLUME MANAGEMENT SYSTEMS FOR PEOPLE WITH LIMB LOSS
DRM - CENTER FOR THE INTREPID
UNIVERSITY OF WASHINGTON
9/11/20192019USAMRAAArmy
22
CRADA-Cooperative Research & Development Agreement
THE MOLECULAR PAP
DCI - DEPARTMENT OF CLINICAL INVESTIGATION
GYPSY BAY GENOMICS
9/10/20192019Army
23
CRADA-Cooperative Research & Development Agreement
A RANDOMIZED, MULTICENTER, OPEN-LABEL, PHASE 3 STUDY TO COMPARE THE EFFICACY AND SAFETY OF ACALABRUTINIB (ACP-196) IN COMBINATION WITH VENETOCLAX WITH AND WITHOUT OBINUTUZUMAB COMPARED TO INVESTIGATOR’S CHOICE OF CHEMOIMMUNOTHERAPY IN SUBJECTS WITH PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA WITHOUT DEL(17P) OR TP53 MUTATION
DOM - HEMOTOLOGY ONCOLOGY SERVICE
HJFACERTA PHARMA, LLC9/5/20192019Civilian
24
CRADA-Cooperative Research & Development Agreement
ECOSPOR III: A PHASE 3 MULTICENTER, RANDOMIZEED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF SER-109 VS. PLACEBO TO REDUCE RECURRENCE OF CLOSTRIDIUM DIFFICILE INFECTION (CDI) IN ADULTS WHO HAVE RECEIVED ANTIBACTERIAL DRUG TREATMENT FOR RECURRENT CDI (RCDI). SHORT TITLE: "SERES-012."
DOM - GASTROENTEROLOGY SERVICEGENEVA
SERES THERAPEUTICS, INC.
8/16/201912/21/20222019Air Force
25
CRADA-Cooperative Research & Development Agreement
A PHASE 2, RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED, PARALLEL GROUP, MULTIPLE CENTER STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF NGM282 ADMINISTERED FOR 12 WEEKS IN PATIENTS WITH HISTOLOGICALLY CONFIRMED NON-ALCOHOLIC STEATOHEPATITIS (NASH)
DOM - GASTROENTEROLOGY SERVICEGENEVA
NGM BIOPHARMACEUTICALS AUSTRALIA PTY LTD.
8/9/20199/30/20212019Army
26
CRADA-Cooperative Research & Development Agreement
STRATEGIC MANAGEMENT TO IMPROVE CRT USING MULTI-SITE PACING POST APPROVAL STUDY
DOM - CARDIOLOGY SERVICEGENEVA
BOSTON SCIENTIFIC CRM
7/30/20192019Army
27
CRADA-Cooperative Research & Development Agreement
A PROSTHETIC FOOT EMULATOR TO OPTIMIZE PRESCRIPTION OF PROSTHETIC FEET IN VETERANS AND SERVICE MEMBERS WITH LEG AMPUTATIONS
DRM - CENTER FOR THE INTREPIDHJF
US ARMY MEDICAL RESEARCH ACQUISITION ACTIVITY
7/18/20198/31/20192019Army
28
CRADA-Cooperative Research & Development Agreement
ENTYVIO (VEDOLIZUMAB) LONG-TERM SAFETY STUDY: AN INTERNATIONAL OBSERVATIONAL PROSPECTIVE COHORT STUDY COMPARING VEDOLIZUMAB TO OTHER BIOLOGIC AGENTS IN PATIENTS WITH ULCERATIVE COLITIS OR CROHN’S DISEASE
DOM - GASTROENTEROLOGY SERVICEGENEVA
TAKEDA GLOBAL RESEARCH
7/16/20196/26/20212019
29
CRADA-Cooperative Research & Development Agreement
DECREASING SUICIDE RISK AMONG SERVICE MEMBERS WITH POSTTRAUMATIC STRESS USING WRITTEN EXPOSURE THERAPY
DBH - BEHAVIORAL HEALTH SERVICEUTHSCSA7/15/20192020MRMCArmy
30
CRADA-Cooperative Research & Development Agreement
TARGETING CHRONIC PAIN IN PRIMARY CARE SETTINGS USING INTERNAL BEHAVIORAL HEALTH CONSULTANTS
DBH - BEHAVIORAL HEALTH SERVICEUTHSCSA7/15/20192020MRMCCivilian
31
CRADA-Cooperative Research & Development Agreement
TREATMENT PATTERNS, OUTCOMES, AND PATIENT-REPORTED HEALTH-RELATED QUALITY OF LIFE: A PROSPECTIVE DISEASE REGISTRY OF PATIENTS WITH MANTLE CELL LYMPHOMA TREATED WITH NOVEL AGENTS
DOM - HEMOTOLOGY ONCOLOGY SERVICE
HJF
ASTRAZENECA PHARMACEUTICALS
7/2/20192019Civilian
32
COOP-Cooperative Agreement LetterMORE RESILIENCY RELIABILITY AND VALIDITY
DRM - BRAIN INJURY REHABILITATION SERVICE
HJF6/28/20197/7/20242019USAMRAACivilian
33
COOP-Cooperative Agreement Letter
LUNG ULTRASOUND WITH NEURAL-NET GENERATED POINT-OF-CARE IDENTIFICATION OF INJURY TRIAL (LUNG-POINT)
DOM - PULMONARYGENEVA
UNIFORMED SERVICES UNIVERSITY OF HEALTH SCIENCES
6/24/20197/29/20242019DARPACivilian
34
CRADA-Cooperative Research & Development Agreement
A PHASE 3, RANDOMIZED, STUDY TO ASSESS THE EFFICACY AND SAFETY OF UBLITUXIMAB IN COMBINATION WITH IBRUTINIB COMPARED TO IBRUTINIB ALONE, IN PATIENTS WITH PREVIOUSLY TREATED HIGH-RISK CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
DOM - HEMOTOLOGY ONCOLOGY SERVICE
GENEVATG THERAPEUTICS, INC.5/21/20199/21/20202019Air Force
35
CRADA-Cooperative Research & Development Agreement
A PHASE III STUDY OF BBI-608 IN COMBINATION WITH 5-FLUOROURACIL, LEUCOVORIN, IRINOTECAN (FOLFIRI) IN ADULT PATIENTS WITH PREVIOUSLY TREATED METASTATIC COLORECTAL CANCER (CRC)
DOM - HEMOTOLOGY ONCOLOGY SERVICE
GENEVA
BOSTON BIOMEDICAL, INC.
5/13/201911/2/20222019Air Force
36
CRADA-Cooperative Research & Development Agreement
A PHASE 2, RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED, PARALLEL GROUP, MULTIPLE CENTER STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF NGM282 ADMINISTERED FOR 12 WEEKS IN PATIENTS WITH HISTOLOGICALLY CONFIRMED NON-ALCOHOLIC STEATOHEPATITIS (NASH)
DOM - GASTROENTEROLOGY SERVICEGENEVA
NGM BIOPHARMACEUTICALS AUSTRALIA PTY LTD.
5/1/20199/30/20202019Army
37
CRADA-Cooperative Research & Development Agreement
APIXABAN FOR THE REDUCTION OF THROMBO-EMBOLISM IN PATIENTS WITH DEVICE-DETECTED SUB-CLINICAL ATRIAL FIBRILLATION
DOM - CARDIOLOGY SERVICEGENEVA
HAMILTON HEALTH SCIENCES
4/23/201912/13/20222019Army
38
CRADA-Cooperative Research & Development Agreement
RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO ASSESS CARDIOVASCULAR OUTCOMES FOLLOWING TREATMENT WITH ERTUGLIFLOZIN (MK-8835/PF-04971729) IN SUBJECTS WITH TYPE 2 DIABETES MELLITUS AND ESTABLISHED VASCULAR DISEASE
DOM - CARDIOLOGY SERVICEGENEVAPFIZER4/23/201910/30/20192019Army
39
CRADA-Cooperative Research & Development Agreement
A LONG-TERM EXTENSION STUDY TO EVALUATE THE SAFETY OF FILGOTINIB IN SUBJECTS WITH CROHN’S DISEASE." SHORT TITLE: "GS-US-419-3896."
DOM - GASTROENTEROLOGY SERVICEGENEVAGILEAD SCIENCES, INC.4/5/20191/21/20232019Air Force
40
CRADA-Cooperative Research & Development Agreement
A LONG TERM-EXTENSION STUDY TO EVALUATE THE SAFETY OF FILGOTINIB IN SUBJECTS WITH ULCERATIVE COLITIS
DOM - GASTROENTEROLOGY SERVICEGENEVAGILEAD SCIENCES, INC.4/5/20194/8/20232019Air Force
41
COOP-Cooperative Agreement Letter
ASSESSING REHABILITATION OUTCOMES AFTER SEVERE NEUROMUSCULOSKELETAL INJURY: DEVELOPMENT OF PATIENT REPORTED OUTCOMES ASSESSMENT INSTRUMENTS
DOO - ORTHOPAEDIC SERVICE (CFI)HJF
UNIVERSITY OF Delaware
4/3/20192019USAMRAACivilian
42
Data-Use Agreement
DATA SHARING AGREEMENT BETWEEN THE JOINT PATHOLOGY CENTER (JPC)AND BROOKE ARMY MEDICAL CENTER (BAMC) FOR ACTUR DATA SHARING AGREEMENT FOR RESEARCH PROTOCOL
DOS - OTOLARYNGOLOGY SERVICE
JOINT PATHOLOGY CENTER
3/13/20193/31/20242019Air Force
43
CRADA-Cooperative Research & Development Agreement
MORE TECH - AUTOMATED ASSESSMENT OF A REHABILITATION OUTCOMESDOO - ORTHOPAEDIC SERVICE (CFI)
OTTO BOCK HEALTHCARE GMBH
3/6/201910/25/20232019Civilian
44
CRADA-Cooperative Research & Development Agreement
A PHASE 2B RANDOMIZED STUDY TO ASSESS THE EFFICACY AND SAFETY OF THE COMBINATION OF UBLITUXIMAB + TGR-1202 WITH OR WITHOUT BENDAMUSTINE AND TGR-1202 ALONE IN PATIENTS WITH PREVIOUSLY TREATED NON-HODGKIN’S LYMPHOMA." SHORT TITLE: "UTX-TGR-205
DOM - HEMOTOLOGY ONCOLOGY SERVICE
GENEVATG THERAPEUTICS, INC.2/22/201912/21/20222019Air Force
45
CRADA-Cooperative Research & Development Agreement
A PHASE 3, DOUBLE-BLIND, RANDOMIZED, LONG-TERM, PLACEBO-CONTROLLED, MULTICENTER STUDY EVALUATING THE SAFETY AND EFFICACY OF OBETICHOLIC ACID IN SUBJECTS WITH NONALCOHOLIC STEATOHEPATITIS.
DOM - GASTROENTEROLOGY SERVICEGENEVA
INTERCEPT PHARMACEUTICALS, INC
2/20/20197/18/20212019Army
46
CRADA-Cooperative Research & Development Agreement
BLOOD SAMPLE COLLECTION TO EVALUATE BIOMARKERS IN SUBJECTS WITH UNTREATED SOLID TUMORS
DOM - HEMOTOLOGY ONCOLOGY SERVICE
GENEVA
EXACT SCIENCES CORPORATION
2/13/20192/21/20242019Air Force
47
CRADA-Cooperative Research & Development Agreement
A SINGLE COHORT PHASE 4 TRIAL INVESTIGATING THE IMPACT OF G-CSF PRIMARY PROPHYLAXIS FOR ADVANCED STAGE HODGKIN LYMPHOMA PATIENTS TREATED WITH A+AVD
DOM - HEMOTOLOGY ONCOLOGY SERVICE
HJFSEATTLE GENETICS2/8/20192/26/20242019Army
48
CRADA-Cooperative Research & Development Agreement
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, DOUBLE DUMMY, PARALLEL GROUP, ACTIVE-CONTROLLED 8-WEEK STUDY TO EVALUATE THE EFFECT OF SACUBITRIL AND VALSARTAN (LCZ696) VERSUS ENALAPRIL ON CHANGES IN NT-PROBNP AND SAFETY AND TOLERABILITY OF IN-HOSPITAL INITIATION OF LCZ696 COMPARED TO ENALAPRIL IN HFREF PATIENTS WHO HAVE BEEN STABILIZED FOLLOWING HOSPITALIZATION FOR ACUTE DECOMPENSATED HEART FAILURE (ADHF).
DOM - CARDIOLOGY SERVICEGENEVA
NOVARTIS PHARMACEUTICALS
2/1/20196/7/20222019Army
49
CRADA-Cooperative Research & Development Agreement
AN OPEN-LABEL, 2 X 2 FACTORIAL, RANDOMIZED CONTROLLED, CLINICAL TRIAL TO EVALUATE THE SAFETY OF APIXABAN VS. VITAMIN K ANTAGONIST AND ASPIRIN VS. ASPIRIN PLACEBO IN SUBJECTS WITH ATRIAL FIBRILLATION AND ACUTE CORONARY SYNDROME OR PERCUTANEOUS CORONARY INTERVENTION
DOM - CARDIOLOGY SERVICEGENEVA
BRISTOL-MYERS SQUIBB COMPANY
1/30/20191/31/20212019Army
50
CRADA-Cooperative Research & Development Agreement
A PHASE 2B, PROSPECTIVE, DOUBLE-BLINDED, RANDOMIZED CONTROLLED TRAIL OF THE MICRONIZED DHACM INJECTION AS COMPARED TO SALINE PLACEBO INJECTION THE TREATMENT OF OSTEOARTHRITIS OF THE KNEE
DOO - ORTHOPAEDIC SERVICEGENEVAMIMEDX GROUP INC.1/28/20192/13/20242019Army
51
CRADA-Cooperative Research & Development Agreement
A PHASE 3, MULTICENTER, OPEN-LABEL EXTENSION TRIAL OF ORAL RPC1063 AS THERAPY FOR MODERATE TO SEVERE ULCERATIVE COLITIS
DOM - GASTROENTEROLOGY SERVICEGENEVACELGENE CORP1/25/20191/21/20232019Air Force
52
CRADA-Cooperative Research & Development Agreement
A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF ORAL RPC1063 AS INDUCTION AND MAINTENANCE THERAPY FOR MODERATE TO SEVERE ULCERATIVE COLITIS.” SHORT TITLE: “RPC01-3101"
DOM - GASTROENTEROLOGY SERVICEGENEVACELGENE CORP1/25/201912/14/20222019Air Force
53
CRADA-Cooperative Research & Development Agreement
A PHASE 2, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY EVALUATING THE EFFICACY AND SAFETY OF FILGOTINIB IN THE TREATMENT OF PERIANAL FISTULIZING CROHN’S DISEASE
DOM - GASTROENTEROLOGY SERVICEGENEVAGILEAD SCIENCES, INC.1/16/201912/14/20222019Air Force
54
COOP-Cooperative Agreement Letter
VALIDATION OF THE START BACK SCREENING TOOL IN PRIMARY CARE MANAGEMENT OF BACK PAIN IN THE MILITARY HEALTH SYSTEM: A RANDOMIZED TRIAL OF RISK-STRATIFIED CARE
DOO - ORTHOPAEDIC SERVICE (CFI)GENEVAUSAMRMC12/28/20182019MRMCArmy
55
MTA-Material Transfer Agreement
A PROSPECTIVE DATABASE REGISTRY OF NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)
DOM - GASTROENTEROLOGY SERVICE
SEATTLE VA MED CENTER
12/6/20182/25/20242019Army
56
CRADA-Cooperative Research & Development Agreement
IDENTIFICATION OF FACTORS THAT INFLUENCE RETURN TO DUTYDRM - CENTER FOR THE INTREPID
SENTIER STRATEGIC RESOURCES, LLC
12/4/20181/9/20212019Civilian
57
COOP-Cooperative Agreement Letter
EXPLORING THE VALUE OF THE DOD/VA CLINICAL PRACTICE GUIDELINES FOR NON-SURGICAL MANAGEMENT OF KNEE OSTEOARTHRITIS IN THE MILITARY HEALTH SYSTEM
DOO - ORTHOPAEDIC SERVICE (CFI)GENEVACDMRP11/13/20182019USAMRAAArmy
58
CRADA-Cooperative Research & Development Agreement
CORE-SCORE PHASE 1: IMPLEMENTATION OF A BRIEF COGNITIVE REHABILITATION INTERVENTION TO ENHANCE EFFICIENCY OF SERVICE DELIVERY FOR SERVICE MEMBERS AND VETERANS WITH MTBI
DRM - BRAIN INJURY REHABILITATION SERVICE
HJFCDMRP11/13/20182/20/20242019CDMRPCivilian
59
CRADA-Cooperative Research & Development Agreement
INDUCTION STUDY #2 - A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF ORAL OZANIMOD AS INDUCTION THERAPY FOR MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE
DOM - GASTROENTEROLOGY SERVICEGENEVACELGENE CORP10/25/20181/24/20242019Air Force
60
CRADA-Cooperative Research & Development Agreement
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF EMRICASAN, AN ORAL CASPASE INHIBITOR, IN SUBJECTS WITH NON-ALCOHOLIC STEATOHEPATITIS (NASH) CIRRHOSIS AND SEVERE PORTAL HYPERTENSION
DOM - GASTERENTOLOGY SERVICEGENEVA
CONATUS PHARMACEUTICALS
10/16/201812/21/20212019Army
61
CRADA-Cooperative Research & Development Agreement
A RANDOMIZED, CONTROLLED, OPEN-LABEL, GLOBAL PHASE 3 STUDY COMPARING THE EFFICACY OF THE ANTI-PD-1 ANTIBODY BGB-A317 VERSUS CHEMOTHERAPY AS SECOND LINE TREATMENT IN PATIENTS WITH ADVANCED UNRESECTABLE/METASTATIC ESOPHAGEAL SQUAMOUS CELL CARCINOMA." SHORT TITLE: "BGB-A317-302
DOM - HEMOTOLOGY ONCOLOGY SERVICE
GENEVA
HEALTH RESEARCHTX LLC
10/15/20182019Army
62
CRADA-Cooperative Research & Development Agreement
EVALUATING THE DIAGNOSTIC PERFORMANCE OF NEAR INFRARED SPECTROSCOPY (NIRS) IN THE SETTING OF ACUTE COMPARTMENT SYNDROME (ACS) IN TRAUMATIZED LOWER EXTREMITIE
DOO - ORTHOPAEDIC SERVICEGENEVANONIN, INC.10/9/20181/22/20242019Air Force
63
CRADA-Cooperative Research & Development Agreement
MICROCURRENT THERAPY FOR CHRONIC LOW BACK PAIN: A RANDOMIZED CONTROLLED TRIAL
DCIS - NURSING OPERATIONS - CNSCIGENEVA
UNIFORMED SERVICES UNIVERSITY OF HEALTH SCIENCES
9/25/201810/22/20232019
TRI-NURSING
Army
64
CRADA-Cooperative Research & Development Agreement
A RANDOMIZED PHASE 3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ENZASTAURIN PLUS R-CHOP VERSUS R-CHOP IN TREATMENT-NAÏVE SUBJECTS WITH HIGH-RISK DIFFUSE LARGE B-CELL LYMPHOMA WHO POSSESS THE NOVEL GENOMIC BIOMARKER DGM1 (“CLINICAL STUDY”)
DOM - HEMOTOLOGY ONCOLOGY SERVICE
HJF
DENOVO BIOPHARMA, LLC
9/13/20189/28/20232018
65
MTA-Material Transfer Agreement
ULTRASOUND DETECTION OF PNEUMOTHORAX BY MILITARY MEDICS PREVIOUSLY NAÏVE TO SONOGRAPHY. A SINGLE-BLINDED CROSS-SECTIONAL STUDY DESIGN USING CADAVER MODELS
DEM - EMERGENCY MEDICINE
FUJIFILM SONOSITE
9/7/20189/21/20232018
66
CRADA-Cooperative Research & Development Agreement
TELEHEALTH 2.0: PRESERVING CONTINUITY OF BEHAVIORAL HEALTH CLINICAL CARE TO PATIENTS USING MOBILE DEVICES
DBH - BEHAVIORAL HEALTH SERVICEUTHSCSACDMRP8/13/20189/29/20202019CDMRPUSPHS
67
CRADA-Cooperative Research & Development Agreement
A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF ORAL RPC1063 AS INDUCTION AND MAINTENANCE THERAPY FOR MODERATE TO SEVERE ULCERATIVE COLITIS.” SHORT TITLE: “RPC01-3101"
DOM - GASTROENTEROLOGY SERVICEGENEVACELGENE CORP8/13/201812/14/20222018
68
CRADA-Cooperative Research & Development Agreement
PATTERNS OF HEALTHCARE UTILIZATION AFTER MUSCULOSKELETAL INJURIES OF THE SPINE AND UPPER EXTREMITY IN THE MHS
DRM - PHYSICAL THERAPY SERVICE
DUKE UNIVERSITY
CDMRP8/10/201811/5/20222019CDMRPArmy
69
CRADA-Cooperative Research & Development Agreement
Healthcare Utilization Patterns in Patients with Lower Extremity InjuriesDRM - PHYSICAL THERAPY SERVICE
DUKE UNIVERSITY
CDMRP8/10/201811/5/20222019CDMRPArmy
70
CRADA-Cooperative Research & Development Agreement
A PHASE III STUDY OF BBI-608 IN COMBINATION WITH 5-FLUOROURACIL, LEUCOVORIN, IRINOTECAN (FOLFIRI) IN ADULT PATIENTS WITH PREVIOUSLY TREATED METASTATIC COLORECTAL CANCER (CRC)
DOM - HEMOTOLOGY ONCOLOGY SERVICE
GENEVA
BOSTON BIOMEDICAL, INC.
8/10/201811/2/20222018Air Force
71
CRADA-Cooperative Research & Development Agreement
A PHASE 3, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF OBETICHOLIC ACID IN SUBJECTS WITH COMPENSATED CIRRHOSIS DUE TO NONALCOHOLIC STEATOHEPATITIS
DOM - GASTROENTEROLOGY SERVICEGENEVA
INTERCEPT PHARMACEUTICALS, INC
8/6/20188/14/20232018
72
CRADA-Cooperative Research & Development Agreement
TRAUMA OUTCOMES AND UROGENITAL HEALTH IN OEF/OIF (TOUGH) – A RETROSPECTIVE COHORT STUDY WITH LONG-TERM FOLLOW-UP
DOS - UROLOGY SERVICEUTHSCSA7/23/20188/24/20232018
73
CRADA-Cooperative Research & Development Agreement
A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, MULTICENTER STUDY TO ASSESS THE EFFICACY AND SAFETY OF OMECAMTIV MECARBIL ON MORTALITY AND MORBIDITY IN SUBJECTS WITH CHRONIC HEART FAILURE WITH REDUCED EJECTION FRACTION
DOM - CARDIOLOGY SERVICEGENEVAAMGEN, INC.7/17/20184/8/20232018
74
CRADA-Cooperative Research & Development Agreement
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP, ACTIVE-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF LCZ696 COMPARED TO VALSARTAN, ON MORBIDITY AND MORTALITY IN HEART FAILURE PATIENTS (NYHA CLASS II-IV) WITH PRESERVED EJECTION FRACTION
DOM - CARDIOLOGY SERVICEGENEVA
NOVARTIS PHARMACEUTICALS CORP.
7/11/20182/8/20202018
75
CRADA-Cooperative Research & Development Agreement
A PROSPECTIVE NON-INVASIVE STUDY OF CEREBRAL BLOOD FLOW VELOCITY MORPHOLOGY FOR QUANTIFICATION OF INTRACRANIAL PRESSURE
DOS - SURGICAL CRITICAL CARE SERVICEHJFNEURAL ANALYTICS INC6/21/20187/31/20222018
76
CRADA-Cooperative Research & Development Agreement
STUDY TO EVALUATE THE EFFECT OF DAPAGLIFLOZIN ON THE INCIDENCE OF WORSENING HEART FAILURE OR CARDIOVASCULAR DEATH IN PATIENTS WITH CHRONIC HEART FAILURE WITH REDUCED EJECTION FRACTION
DOM - CARDIOLOGY SERVICEGENEVA
ASTRAZENECA PHARMACEUTICALS
5/31/20188/15/20222018
77
CRADA-Cooperative Research & Development Agreement
ESTABLISHMENT OF A TISSUE REPOSITORY FOR THE MURTHA CANCER CENTER BIOBANK (MCCB) AT BAMC
DPALS - PATHOLOGY SERVICEHJF
UNIFORMED SERVICES UNIVERSITY OF HEALTH SCIENCES
5/16/20186/30/20232018
78
CRADA-Cooperative Research & Development Agreement
PATTERN OF USE AND SAFETY/EFFECTIVENESS OF NIVOLUMAB IN ROUTINE ONCOLOGY PRACTICE
DOM - HEMOTOLOGY ONCOLOGY SERVICE
GENEVA
BRISTOL-MYERS SQUIBB COMPANY
4/23/20187/13/20222018
79
CRADA-Cooperative Research & Development Agreement
A PATIENT TOOLKIT FOR THE TRANSITION OF CARE OF ACTIVE DUTY PATIENTS WITH IBD TO THE VETERANS ADMINISTRATION HEALTHCARE SYSTEM
DOM - GASTERENTOLOGY SERVICEGENEVA
AMERICAN COLLEGE OF GASTROENTEROLOGY
4/16/20187/21/20232018
80
CRADA-Cooperative Research & Development Agreement
A PHASE 2, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY EVALUATING THE EFFICACY AND SAFETY OF FILGOTINIB IN THE TREATMENT OF PERIANAL FISTULIZING CROHN’S DISEASE
DOM - GASTROENTEROLOGY SERVICEGENEVAGILEAD SCIENCES, INC.4/13/201812/14/20222018
81
CRADA-Cooperative Research & Development Agreement
A PHASE 3, MULTICENTER, OPEN-LABEL EXTENSION TRIAL OF ORAL RPC1063 AS THERAPY FOR MODERATE TO SEVERE ULCERATIVE COLITIS
DOM - GASTROENTEROLOGY SERVICEGENEVACELGENE CORP4/5/20181/21/20232018
82
CRADA-Cooperative Research & Development Agreement
ECOSPOR IV: AN OPEN-LABEL EXTENSION OF STUDY SERES-012 EVALUATING SER-109 IN ADULT SUBJECTS WITH RECURRENT CLOSTRIDIUM DIFFICILE INFECTION (RCDI). SHORT TITLE: "SERES-013."
DOM - GASTROENTEROLOGY SERVICEGENEVA
SERES THERAPEUTICS, INC.
4/5/201812/21/20222018
83
CRADA-Cooperative Research & Development Agreement
A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, MULTICENTER STUDY TO ASSESS THE EFFICACY AND SAFETY OF OMECAMTIV MECARBIL ON MORTALITY AND MORBIDITY IN SUBJECTS WITH CHRONIC HEART FAILURE WITH REDUCED EJECTION FRACTION
DOM - CARDIOLOGY SERVICEGENEVAAMGEN, INC.3/19/20184/8/20232018
84
CRADA-Cooperative Research & Development Agreement
MORE TECH - AUTOMATED ASSESSMENT OF A REHABILITATION OUTCOMESDOO - ORTHOPAEDIC SERVICE (CFI)
OTTO BOCK HEALTHCARE GMBH
3/16/201810/25/20232019Civilian
85
CRADA-Cooperative Research & Development Agreement
AMENDMENT 1 TO MASTER CRADA
DCI - DEPARTMENT OF CLINICAL INVESTIGATION
METIS3/12/20182018
86
CRADA-Cooperative Research & Development Agreement
A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF ORAL RPC1063 AS INDUCTION AND MAINTENANCE THERAPY FOR MODERATE TO SEVERE ULCERATIVE COLITIS.” SHORT TITLE: “RPC01-3101"
DOM - GASTROENTEROLOGY SERVICEGENEVACELGENE CORP3/8/201812/14/20222018
87
CRADA-Cooperative Research & Development Agreement
“A MULTINATIONAL, MULTICENTER, RANDOMIZED, PHASE 3 STUDY OF TESETAXEL PLUS A REDUCED DOSE OF CAPECITABINE VERSUS CAPECITABINE ALONE IN PATIENTS WITH HER2 NEGATIVE, HORMONE RECEPTOR POSITIVE, LOCALLY ADVANCED OR METASTATIC BREAST CANCER PREVIOUSLY TREATED WITH A TAXANE”. SHORT TITLE, “ODENATE 2018.023”
DOM - HEMOTOLOGY ONCOLOGY SERVICE
HJF
ODONATE THERAPEUTICS LLC
3/7/20183/31/20232018
88
CRADA-Cooperative Research & Development Agreement
STELLARIS: A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF CENICRIVIROC FOR THE TREATMENT OF LIVER FIBROSIS IN ADULT SUBJECTS WITH NONALCOHOLIC STEATOHEPATITIS
DOM - GASTERENTOLOGY SERVICEGENEVAALLERGAN PLC2/26/20184/9/20232018
89
CRADA-Cooperative Research & Development Agreement
EFFICACY STUDY OF INECALCITOL IN COMBINATION WITH DECITABINE IN ACUTE MYELOID LEUKEMIA PATIENTS UNFIT FOR STANDARD CHEMOTHERAPY
DOM - HEMOTOLOGY ONCOLOGY SERVICE
HJFHYBRIGENICS2/26/20183/31/20232018
90
CRADA-Cooperative Research & Development Agreement
COMBINED PHASE 2B/3, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDIES EVALUATING THE EFFICACY AND SAFETY OF FILGOTINIB IN THE INDUCTION AND MAINTENANCE OF REMISSION IN SUBJECTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS
DOM - GASTROENTEROLOGY SERVICEGENEVAGILEAD SCIENCES, INC.2/20/20184/8/20232018
91
MTA-Material Transfer Agreement
LUNG ULTRASOUND WITH NEURAL-NET GENERATED POINT-OF-CARE IDENTIFICATION OF INJURY TRIAL (LUNG-POINT)
DOM - PULMONARY
INVENTIVE GOVERNMENT SOLUTIONS, LLC
2/20/20182018
92
CRADA-Cooperative Research & Development Agreement
ENTYVIO (VEDOLIZUMAB) LONG-TERM SAFETY STUDY: AN INTERNATIONAL OBSERVATIONAL PROSPECTIVE COHORT STUDY COMPARING VEDOLIZUMAB TO OTHER BIOLOGIC AGENTS IN PATIENTS WITH ULCERATIVE COLITIS OR CROHN’S DISEASE
DOM - GASTROENTEROLOGY SERVICEGENEVA
TAKEDA GLOBAL RESEARCH
2/14/20186/26/20212018
93
CRADA-Cooperative Research & Development Agreement
A PHASE 3 STUDY COMPARING DARATUMUMAB, LENALIDOMIDE, AND DEXAMETHASONE (DRD) VS LENALIDOMIDE AND DEXAMETHASONE (RD) IN SUBJECTS WITH PREVIOUSLY UNTREATED MULTIPLE MYELOMA WHO ARE INELIGIBLE FOR HIGH DOSE THERAPY
DOM - HEMOTOLOGY ONCOLOGY SERVICE
GENEVA
JANSSEN RESEARCH & DEVELOPMENT LLC
2/14/201812/20/20252018
94
MTA-Material Transfer Agreement
A PROSPECTIVE DATABASE REGISTRY OF NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)
DOM - GASTROENTEROLOGY SERVICE
WESTMEAD INSTITUTE FOR MEDICAL RESEARCH
2/5/20182018
95
MTA-Material Transfer Agreement
MULTI-INSTITUTIONAL, PROSPECTIVE STUDY OF DIRECT SINGLE-STAGE IMPLANTATION OF SACRAL NEUROMODULATION
DOS - UROLOGY SERVICE
LOMA LINDA UNIVERSITY MED CTR
1/30/20184/8/20202018
96
CRADA-Cooperative Research & Development Agreement
A PHASE 2, RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED, PARALLEL GROUP, MULTIPLE CENTER STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF NGM282 ADMINISTERED FOR 12 WEEKS IN PATIENTS WITH HISTOLOGICALLY CONFIRMED NON-ALCOHOLIC STEATOHEPATITIS (NASH)
DOM - GASTROENTEROLOGY SERVICEGENEVA
NGM BIOPHARMACEUTICALS AUSTRALIA PTY LTD.
1/3/20189/30/20202018
97
MTA-Material Transfer AgreementAmerican College of Radiology NORMATIVE NEUROIMAGING LIBRARYDOR - RADIOLOGY SERVICE
HEALTH RESEARCHTX LLC
12/27/20172/20/20232018
98
CRADA-Cooperative Research & Development Agreement
A LONG-TERM EXTENSION STUDY TO EVALUATE THE SAFETY OF FILGOTINIB IN SUBJECTS WITH CROHN’S DISEASE." SHORT TITLE: "GS-US-419-3896."
DOM - GASTROENTEROLOGY SERVICEGENEVAGILEAD SCIENCES, INC.12/18/20171/21/20232018
99
CRADA-Cooperative Research & Development Agreement
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF EMRICASAN, AN ORAL CASPASE INHIBITOR, IN SUBJECTS WITH NON-ALCOHOLIC STEATOHEPATITIS (NASH) CIRRHOSIS AND SEVERE PORTAL HYPERTENSION SHORT TITLE: "IDN-6556-14"
DOM - GASTROENTEROLOGY SERVICEGENEVA
CONATUS PHARMACEUTICALS
12/14/201712/21/20222018
100
CRADA-Cooperative Research & Development Agreement
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED TRIAL OF EMRICASAN, AN ORAL CASPASE INHIBITOR, IN SUBJECTS WITH DECOMPENSATED NON-ALCOHOLIC STEATOHEPATITIS (NASH) CIRRHOSIS" SHORT TITLE: "IDN-6556-17"
DOM - GASTERENTOLOGY SERVICEGENEVA
CONATUS PHARMACEUTICALS
12/8/201712/21/20222018